期刊文献+

维生素C透析液血液透析滤过对氧化应激和血管内皮功能的影响 被引量:5

Effect of hemodiafiltration with VitC dialysate on the oxidative stress and endothelial function
原文传递
导出
摘要 目的探讨维生素C透析液在血液透析滤过(HDF)中的应用对改善患者的氧化应激状态及对血管内皮功能的影响。方法选择本院血液净化中心稳定的维持性血液透析(MHD)患者10例进行自身交叉对照研究,分别测定常规透析液和VitC透析液HDF治疗前后血浆总抗坏血酸(TAA)、维生素E(VitE)、高级蛋白质氧化产物(AOPP)、血浆和红细胞丙二醛(MDA)等氧化还原指标。应用B超检测流量依赖的血管内皮舒张功能(FDD)。ELISA法检测治疗前后血清孵育体外培养的人脐静脉内皮细胞(HUVEC)分泌或表达可溶性细胞间黏附分子1(sICAM-1)、单核细胞趋化分子1(MCP-1)的水平。结果常规HDF治疗后,血浆TAA、VitE水平较治疗前显著下降(P〈0.01)。VitC透析液HDF治疗后,血浆TAA较治疗前显著升高[(39.48±27.63)比(222.18±90.09)μmol/L,P〈0.01],但VitE水平仍较治疗前显著下降[(6.80±2.08)比(4.54±2.39)μmol/L,|P〈0.05]。常规HDF治疗后,肱动脉反应性舒张最大直径增长率(%)和最大流量增长率(%)均较治疗前显著下降(14.3±5.35比8.96±2.66,P〈0.01;67.82±32.32比33.34±15.23,P〈0.05)。VitC透析液HDF治疗后,上述指标与治疗前差异无统计学意义(10.44±5.49比11.42±8.61,60.29±38.15比70.53±56.05,P均〉0.05)。常规HDF治疗后的血清孵育HUVEC 24 h上清液中,sICAM-1、MCP-1浓度显著高于治疗前(P〈0.01),而VitC透析液HDF治疗对HUVEC分泌sICAM-1、MCP-1无显著影响。结论常规HDF治疗由于大量抗氧化剂VitC的丢失,对MHD患者的内皮细胞功能有一定程度损伤。VitC透析液HDF治疗可减轻氧化应激对内皮细胞功能的损伤。 Objective To explore the effect of VitC dialysate HDF on the oxidative stress and endothelial function. Methods Ten stable maintenance hemodialysis patients were enrolled in the research. The efficency of VitC dialysate HDF was compared with the regular HDF in prospective, self-cross way. Their plasma levels of total ascorbic acid (TAA), atocopherol, advanced oxidative protein products (AOPP) and malondialdehydea (MDA) were detected pre- and post-treatment of regular HDF or VitC dialysate HDF. The flow dependent vascular dilation (FDD) was measured by high-resolution B-mode uhrasonograph. The pre- and post-treatment serum was incubated with HUVEC, and then the levels of sICAM-1 and MCP-1 in the supernate were tested respectively. Results After regular HDF, the plasma levels of TAA and α-tocopherol decreased significantly[(39.78±21.52) vs. (21.51±13.88) μmol/L, (7.77±2.33) vs. (5.28±1.87) μmol/L, P〈 0.01], except for AOPP, MDA. After treated with VitC dialysate HDF, plasma TAA was significantly higher than before [(39.48±27.63) vs, (222.18±90.09) μmol/L, P〈0.01], and α- tocopherol was significantly lower [(6.80±2.08) vs, (4.54±2.39) μmol/L, P〈0.05]. FDD was markedly impaired after regular HDF( 14.3±5.35 vs. 8.96±2.66, P〈0.01; 67.82±32.32 vs. 33.34± 15.23, P〈0.05), but no obvious change was found after VitC dialysate HDF (10.44±5.49 vs. 11.42±8.61, 60.29±38.15 vs. 70.53±56.05, P〉0.05). The post-treatment serum of regular HDF significantly stimulated the HUVEC secreting sICAM-1 and MCP-1, but such stimulation was not found by VitC dialysate HDF. Conclusions Regular HDF impairs the endothelial function probably for the VitC losing and high oxidative stress. The VitC dialysate HDF may be a good way to dissolve the problem partly.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2007年第10期621-625,共5页 Chinese Journal of Nephrology
关键词 血液透析滤过 抗坏血酸 氧化应激 内皮细胞 Hemodiafiltration Aseorbie acid Oxidative stress Endothelial cell
  • 相关文献

参考文献12

  • 1Mydlik M, Derzsiova K, Racz O, et al. A modified dialyzer with vitamin E and antioxidant defense parameters. Kidney Int Suppl, 2001,78:S144-S147.
  • 2Gerdemann A, Wagner Z, Solf A, et al. Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality. Nephrol Dial Transplant, 2002, 17:1045-1049.
  • 3Panichi V, Rizza GM, Taccola D, et al. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Biomed Pharmacother, 2006, 60: 14-17.
  • 4Liakopoulos V, Eleftheriadis T, Kyropoulos T, et al. Hemodialysis procedure does not affect the levels of sICAM and sVCAM-1 in patients with end stage renal disease. Ren Fail,2005, 27: 315-321.
  • 5Grooteman MP, Gritters M, Wauters IM, et al. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients. Nephrol Dial Transplant, 2005, 20: 2751-2758.
  • 6Roselaar SE, Nazhat NB, Winyard PG, et al. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int, 1995, 48: 199-206.
  • 7Morena M, Cristol JP, Bosc JY, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant, 2002, 17: 422-427.
  • 8丁峰,朱秋毓,顾勇,林善锬.高级氧化蛋白产物的主要成分分析[J].中华肾脏病杂志,2006,22(1):33-36. 被引量:11
  • 9Gerdemann A, Wagner Z, Solf A, et al. Plasma levels of advanced glycation end products during haemodialysis, haemodiafihration and haemofiltration: potential importance of dialysate quality. Nephrol Dial Transplant, 2002, 17:1045-1049.
  • 10Kosch M, Levers A, Fobker M, et al. Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress. Nephrol Dial Transplant, 2003, 18: 1370-1375.

二级参考文献8

  • 1Dhamraita SS,Stephensa JW,Coopera JA,et al.Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2.Eur Heart J Arch,2004,25:468-475.
  • 2Locatelli F,Canaud B,Eckarkt KU,et al.Oxidative stress in end-stage renal disease:an emerging threat to patient outcome.Nephrol Dial Transplant,2003,18:1272-1280.
  • 3Witko-Sarsat V,Friedlander M,Nguyen-Khoa T,et al.Advanced oxidation protein products as novel mediator of inflammation and monocyte activation in chronic renal failure.J Immunol,1998,161:2524-2532.
  • 4Shacter E.Quantification and significance of protein oxidation in biological samples.Drug Metab Rev,2000,32:307-326.
  • 5Levine RL,Garland D,Oliver CN,et al,Determination of carbonyl content in oxidatively modified proteins.Methods Enzymol,1990,186:464-468.
  • 6Yan LJ,Orr WC,Sohal RS.Identification of oxidized proteins based on sodium dodecyl sulfate-polyacrylamide gel electrophoresis,immunochemical detection,isoelectric focusing,and microsequencing.Analytical Biochem,1998,263:67-71.
  • 7Reznick AZ,Packer L.Oxidative damage to proteins:Spectrophotometric method for carbonyl assay.Methods Enzymol,1994,233:357-363.
  • 8Himmelfarb J,McMonagle E.Albumin is the major plasma protein target of oxidant stress in uremia.Kidney Int,2001,60:358-363.

共引文献10

同被引文献73

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部